Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

被引:8
作者
Chen, Yi [1 ]
Mazur, Curt [2 ]
Luo, Yi [1 ]
Sun, Linhong [1 ]
Zhang, Mingdi [1 ]
McCampbell, Alex [1 ]
Tomassy, Giulio Srubek [1 ]
机构
[1] Biogen Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA
[2] Ionis Pharmaceut, Carlsbad, CA USA
来源
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS | 2019年 / 152期
关键词
Neuroscience; Issue; 152; antisense oligonucleotides; blood brain barrier; central nervous system; intrathecal delivery; rat; RNA; spinal cord; OLIGODEOXYNUCLEOTIDES; BARRIERS;
D O I
10.3791/60274
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The blood brain barrier (BBB) is an important defense against the entrance of potentially toxic or pathogenic agents from the blood into the central nervous system (CNS). However, its existence also dramatically lowers the accessibility of systemically administered therapeutic agents to the CNS. One method to overcome this, is to inject those agents directly into the cerebrospinal fluid (CSF), thus bypassing the BBB. This can be done via implantation of a catheter for either continuous infusion using an osmotic pump, or for single bolus delivery. In this article, we describe a surgical protocol for delivery of CNS-targeting antisense oligonucleotides (ASOs) via a catheter implanted directly into the cauda equina space of the adult rat spine. As representative results, we show the efficacy of a single bolus ASO intrathecal (IT) injection via this catheterization system in knocking down the target RNA in different regions of the rat CNS. The procedure is safe, effective and does not require expensive equipment or surgical tools. The technique described here can be adapted to deliver drugs in other modalities as well.
引用
收藏
页数:6
相关论文
共 23 条
  • [1] Dynamics of CNS barriers: Evolution, differentiation, and modulation
    Abbott, NJ
    [J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2005, 25 (01) : 5 - 23
  • [2] The blood-brain barrier: an overview - Structure, regulation, and clinical implications
    Ballabh, P
    Braun, A
    Nedergaard, M
    [J]. NEUROBIOLOGY OF DISEASE, 2004, 16 (01) : 1 - 13
  • [3] Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
    Becker, Lindsay A.
    Huang, Brenda
    Bieri, Gregor
    Ma, Rosanna
    Knowles, David A.
    Jafar-Nejad, Paymaan
    Messing, James
    Kim, Hong Joo
    Soriano, Armand
    Auburger, Georg
    Pulst, Stefan M.
    Taylor, J. Paul
    Rigo, Frank
    Gitler, Aaron D.
    [J]. NATURE, 2017, 544 (7650) : 367 - +
  • [4] A new look at cerebrospinal fluid circulation
    Brinker T.
    Stopa E.
    Morrison J.
    Klinge P.
    [J]. Fluids and Barriers of the CNS, 11 (1)
  • [5] Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches
    Cardoso, Filipa Lourenco
    Brites, Dora
    Brito, Maria Alexandra
    [J]. BRAIN RESEARCH REVIEWS, 2010, 64 (02) : 328 - 363
  • [6] RNA-Targeted Therapeutics
    Crooke, Stanley T.
    Witztum, Joseph L.
    Bennett, C. Frank
    Baker, Brenda F.
    [J]. CELL METABOLISM, 2018, 27 (04) : 714 - 739
  • [7] Brain barriers in health and disease
    Daneman, Richard
    Engelhardt, Britta
    [J]. NEUROBIOLOGY OF DISEASE, 2017, 107 : 1 - 3
  • [8] Direct Intraventricular Delivery of Drugs to the Rodent Central Nervous System
    DeVos, Sarah L.
    Miller, Timothy M.
    [J]. JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2013, (75): : e50326
  • [9] Goodkey K, 2018, METHODS MOL BIOL, V1828, P69, DOI 10.1007/978-1-4939-8651-4_4
  • [10] Tight junction modulation of the blood brain barrier: CNS delivery of small molecules
    Greene, Chris
    Campbell, Matthew
    [J]. TISSUE BARRIERS, 2016, 4 (01):